专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

21. 发明申请

US20130022684A1 ORAL PHARMACEUTICAL COMPOSITION COMPRISING FENOFIBRIC ACID AND AN ALKALIFYING AGENT 审中-公开
标题翻译：含有抗坏血酸和碱性化合物的口服药物组合物
公开(公告)号：US20130022684A1
公开(公告)日：2013-01-24
申请号：US13637530
申请日：2011-04-12
申请人： Ki Young Jang , Mijin Park , Kyeong Soo Kim , Yong Il Kim , Jae Hyun Park , Jong Soo Woo
发明人： Ki Young Jang , Mijin Park , Kyeong Soo Kim , Yong Il Kim , Jae Hyun Park , Jong Soo Woo
IPC分类号： A61K9/14 , A61K9/20 , B29B9/12 , A61K31/192 , A61K9/00
CPC分类号： A61K9/1611 , A61K9/1617 , A61K9/1623 , A61K9/1652 , A61K9/5026 , A61K9/5042 , A61K9/5047 , A61K31/192
摘要： An oral pharmaceutical composition of the present invention comprising fenofibric acid or a pharmaceutically acceptable salt thereof, and 0.22 to 1 part by weight of an alkalifying agent based on 1 part by weight of fenofibric acid has improved bioavailability and a minimized absorption deviation in the gastrointestinal tract, which is useful in treating hyperlipidemia and hypertriglyceridemia.
摘要翻译：包含非诺贝酸或其药学上可接受的盐的本发明的口服药物组合物和基于1重量份非诺贝酸的0.22至1重量份的碱化剂具有改善的生物利用度和最小化的胃肠道吸收偏差，其可用于治疗高脂血症和高甘油三酯血症。

22. 发明申请

US20120044149A1 MISINPUT AVOIDANCE METHOD FOR MOBILE TERMINAL 审中-公开
标题翻译：移动终端的MISINPUT避免方法
公开(公告)号：US20120044149A1
公开(公告)日：2012-02-23
申请号：US13213926
申请日：2011-08-19
申请人： Dong Kyun Son , Dong Han Kang , Woo Chan Park , Jong Soo Woo , Sang Hoon Kang
发明人： Dong Kyun Son , Dong Han Kang , Woo Chan Park , Jong Soo Woo , Sang Hoon Kang
IPC分类号： G06F3/023
CPC分类号： G06F3/023
摘要： A misinput avoidance method of a mobile terminal may be implemented to prevent a misinput caused by contacting unintended keys around the target key. A misinput avoidance method of a mobile terminal according to the present invention includes detecting inputs of a plurality of keys and discriminating a target key from other keys. The method also includes extracting keys around the target key and registering the keys around the target keys as neighbor keys. The method further includes processing the input of the target key while blocking the inputs of the neighbor keys. The method further includes releasing, when the target key is released, the blocking of the inputs of the neighbor keys.
摘要翻译：可以实现移动终端的误输入回避方法，以防止由于围绕目标密钥接触意外的密钥造成的误输。根据本发明的移动终端的误输入回避方法包括检测多个密钥的输入并且将目标密钥与其他密钥相区别。该方法还包括提取围绕目标密钥的密钥并将目标密钥周围的密钥注册为相邻密钥。该方法还包括处理目标密钥的输入，同时阻挡相邻密钥的输入。该方法还包括当目标密钥被释放时释放邻居密钥的输入的阻塞。

23. 发明授权

US06451128B1 Method for manufacturing high magnetic flux denshy grain oriented electrical steel sheet based on low temperature slab heating method 有权
标题翻译：基于低温板坯加热方法制造高磁通密度晶粒取向电工钢板的方法
公开(公告)号：US06451128B1
公开(公告)日：2002-09-17
申请号：US09242865
申请日：1999-02-25
申请人： Chung San Lee , Chan Hye Han , Jong Soo Woo , Gyu Seung Choi , Jae Kwan Kim , Byung Deuk Hong , Kyu Seok Han
发明人： Chung San Lee , Chan Hye Han , Jong Soo Woo , Gyu Seung Choi , Jae Kwan Kim , Byung Deuk Hong , Kyu Seok Han
IPC分类号： H01F1147
CPC分类号： C21D3/04 , C21D8/1255 , C21D8/1272
摘要： A method for manufacturing a high magnetic flux density grain oriented electrical steel sheet is disclosed. A silicon steel slab is heated and hot-rolled, and the steel sheet is annealed and cold-rolled and decarburized. An annealing separator is spread on the steel sheet, and a final high temperature annealing is carried out. The silicon steel contains in weight % 0.02-0.045% of C, 2.90-3.30% of Si, 0.05-0.30% of Mn, 0.005-0.019% of Al, 0.003-0.008% of N, 0.006% or less of S (the above being main ingredients), 0.001-0.012% of B, and a balance of Fe and unavoidable impurities; or the above main ingredients plus 0.30-0.70% of Cu, 0.03-0.07% of Ni, 0.03-0.07% of Cr, and a balance of Fe and unavoidable impurities; or the above main ingredients plus 0.001-0.012% of B, 0.30-0.70% of Cu, 0.03-0.07% of Ni, 0.03-0.07% of Cr, and a balance of Fe and unavoidable impurities.
摘要翻译：公开了一种制造高磁通密度晶粒取向电工钢板的方法。对硅钢板进行加热热轧，对钢板进行退火冷轧，脱碳。将退火分离器铺展在钢板上，进行最终的高温退火。硅钢的重量％为C：0.02-0.045％，Si：2.90-3.30％，Mn：0.05-0.30％，Al：0.005-0.019％，N：0.003-0.008％，S：0.006％以上为主要成分），0.001-0.012％B，余量为Fe和不可避免的杂质; 或上述主要成分加入Cu 0.30-0.70％，Ni 0.03-0.07％，Cr 0.03-0.07％，余量为Fe和不可避免的杂质; 或上述主要成分加上0.001-0.012％的B，0.30-0.70％的Cu，0.03-0.07％的Ni，0.03-0.07％的Cr，余量的Fe和不可避免的杂质。

24. 发明授权

US5803988A Method for manufacturing non-oriented electrical steel sheet showing superior adherence of insulating coated layer 失效
标题翻译：制造无取向电工钢板的方法，其表现出优异的绝缘涂层粘附性
公开(公告)号：US5803988A
公开(公告)日：1998-09-08
申请号：US894394
申请日：1997-08-18
申请人： Byung Keun Bae , Sam Kyu Chang , Jong Soo Woo , Wun Gul Lee
发明人： Byung Keun Bae , Sam Kyu Chang , Jong Soo Woo , Wun Gul Lee
IPC分类号： C21D3/04 , C21D8/12 , C22C38/02 , H01F1/147 , H01F1/18
CPC分类号： C21D8/1288 , C21D8/1272 , C21D8/1277 , H01F1/147 , H01F1/18 , C21D3/04
摘要： The annealing conditions of a cold rolled steel sheet are properly controlled so as to form a dense surface oxide layer, thereby improving the adherence strength of the insulating layer on non-oriented electrical steel sheet. The method includes the following steps. A steel slab is prepared which is composed of in weight %: 0.05% or less of C, 3.5% or less of Si, 1.5% or less of Mn, 0.15% or less of P, 0.015% or less of S, 1.0% or less of Al, one or more elements selected from a group consisting of 0.03-0.30% of Sn, 0.03-0.3% of Sb, 0.03-1.0% of Ni and 0.03-0.50% of Cu, the balance of Fe and unavoidable impurities. The steel slab is reheated, hot rolled, pickled after annealing or without annealing and cold-rolled. A low temperature annealing is carried out on the cold rolled steel sheet at a temperature of 750.degree.-850.degree. C. for 30 seconds to 5 minutes under a humid atmosphere having a dew point of 25.degree.-65.degree. C. A high temperature annealing is carried out on the low-temperature-annealed cold rolled steel sheet at a temperature of 800.degree.-1070.degree. C. for 10 seconds to 3 minutes under a dry atmosphere having a dew point of 0.degree. C. or below. Insulating layers are coated on the surfaces of the high-temperature-annealed steel sheet, and a hardening heat treatment is carried out on the steel sheet.
摘要翻译： PCT No.PCT / KR96 / 00078 Sec。 371日期：1997年8月18日 102（e）1997年8月18日PCT PCT 1996年6月1日PCT公布。公开号WO97 / 22723 日期1996年6月26日冷轧钢板的退火条件被适当地控制，以形成致密的表面氧化物层，从而提高无取向电工钢板上的绝缘层的粘附强度。该方法包括以下步骤。制备钢板，其重量％：C：0.05％以下，Si：3.5％以下，Mn：1.5％以下，P：0.15％以下，S：0.015％以下，1.0％或更少的Al，一种或多种选自Sn，0.03-0.30％的Sn，0.03-0.3％的Sb，0.03-1.0％的Ni和0.03-0.50％的Cu，其余的Fe和不可避免的杂质。再次加热，热轧，退火或不退火冷轧后酸洗。在露点为25〜-65℃的潮湿气氛下，在750〜-850℃的温度下对冷轧钢板进行低温退火30秒〜5分钟。高温退火在露点为0℃以下的干燥气氛下，在800〜-1070℃的温度下在低温退火冷轧钢板上进行10秒钟〜3分钟。在高温退火钢板的表面上涂布绝缘层，对钢板进行硬化热处理。

25. 发明申请

US20140112962A1 PHARMACEUTICAL COMPOSITION COMPRISING AMIDE DERIVATIVE INHIBITING THE GROWTH OF CANCER CELLS AND NON-METALLIC SALT LUBRICANT 有权
标题翻译：包含酰胺衍生物抑制癌细胞和非金属盐润滑剂生长的药物组合物
公开(公告)号：US20140112962A1
公开(公告)日：2014-04-24
申请号：US14124436
申请日：2012-05-18
申请人： Yong Il Kim , Kyeong Soo Kim , Jin Cheul Kim , Yo Han Kim , Jae Hyun Park , Jong Soo Woo
发明人： Yong Il Kim , Kyeong Soo Kim , Jin Cheul Kim , Yo Han Kim , Jae Hyun Park , Jong Soo Woo
IPC分类号： A61K47/44 , A61K47/26 , A61K47/10 , A61K47/14 , A61K47/02 , A61K47/36 , A61K31/517 , A61K47/12
CPC分类号： A61K47/44 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2031 , A61K9/2077 , A61K31/517 , A61K47/02 , A61K47/06 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/26 , A61K47/36 , C07D401/12
摘要： Disclosed is a pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof and a non-metallic salt lubricant, which can be used as an effective cancer cell-growth inhibitor owing to its enhanced storage stability with no quality changes over time.
摘要翻译：公开了一种药物组合物，其包含其酰胺衍生物或其药学上可接受的盐和非金属盐润滑剂，其可以用作有效的癌细胞生长抑制剂，这是由于其增强的储存稳定性而随时间而没有质量变化。

26. 发明授权

US08673945B2 Solid pharmaceutical composition comprising amlodipine and losartan 有权
标题翻译：包含氨氯地平和氯沙坦的固体药物组合物
公开(公告)号：US08673945B2
公开(公告)日：2014-03-18
申请号：US13140348
申请日：2009-12-28
申请人： Jong Soo Woo , Jae Hyun Park , Young Il Kim , Kyeong Soo Kim , Ho Taek Yim , Ji Hyun Im
发明人： Jong Soo Woo , Jae Hyun Park , Young Il Kim , Kyeong Soo Kim , Ho Taek Yim , Ji Hyun Im
IPC分类号： A61K31/41 , A61K31/44
CPC分类号： A61K31/41 , A61K9/2013 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K9/2077 , A61K9/5084 , A61K31/4178 , A61K31/44 , A61K31/4422 , A61K2300/00
摘要： The present invention relates to a solid pharmaceutical composition for preventing or treating cardiovascular disorders comprising amlodipine and losartan as active ingredients, and a disintegrant which is a mixture of at least two components selected from the group consisting of sodium starch glycolate, crosscarmellose sodium, and crosspovidone, which exhibits a high and stable level of amlodipine and losartan dissolution rates.
摘要翻译：本发明涉及一种用于预防或治疗包含氨氯地平和氯沙坦作为活性成分的心血管疾病的固体药物组合物，和崩解剂，其是选自淀粉羟乙酸钠，交联羧甲基纤维素钠和交联聚维酮的至少两种组分的混合物，其表现出高且稳定的氨氯地平和氯沙坦溶出速率水平。

27. 发明申请

US20090042952A1 Sustained Release Composition for Oral Administration of Niacin 失效
标题翻译：烟酸口服给药缓释组合物
公开(公告)号：US20090042952A1
公开(公告)日：2009-02-12
申请号：US11569269
申请日：2005-05-27
申请人： Jong Soo Woo , Young Hun Kim
发明人： Jong Soo Woo , Young Hun Kim
IPC分类号： A61K31/4406
CPC分类号： A61K31/44 , A61K9/2027 , A61K9/2031 , A61K9/205 , A61K9/2077
摘要： A sustained release composition for oral administration of niacin, comprising niacin; a carrier for sustained release composed of a hydrophilic polymer and a hydrophobic polymer; and a pharmaceutically acceptable additive, the hydrophilic polymer being a polyethylene oxide and a natural gum, is capable of maintaining a constant release rate of niacin.
摘要翻译：口服烟酸的持续释放组合物，其包含烟酸; 由亲水性聚合物和疏水性聚合物组成的持续释放载体; 和药学上可接受的添加剂，亲水性聚合物是聚环氧乙烷和天然树胶，能够保持烟酸的恒定释放速率。

28. 发明授权

US06706285B1 Enteric coated formulation of a benzimidazole derivative and method for preparation thereof 有权
标题翻译：苯并咪唑衍生物的肠溶包衣制剂及其制备方法
公开(公告)号：US06706285B1
公开(公告)日：2004-03-16
申请号：US09357570
申请日：1999-07-20
申请人： Jong Soo Woo
发明人： Jong Soo Woo
IPC分类号： A61K914
CPC分类号： A61K9/5042 , A61K9/2866 , A61K31/4439 , A61K47/585
摘要： Disclosed are an enteric coated formulation of a benzimidazole derivative comprising a core and a film of an enteric coating agent on the surface thereof, the core containing a complex of the benzimidazole derivative and an ion-exchange resin, and the enteric coating agent having the degree of substitution by an acidic group of less than 30%, and a method for preparation thereof.
摘要翻译：本发明公开了一种苯并咪唑衍生物的肠溶包衣制剂，其包含核心和其表面上的肠溶衣的膜，所述核心包含苯并咪唑衍生物和离子交换树脂的复合物，以及具有度的低于30％的酸性基团的取代基及其制备方法。

29. 发明授权

US5639474A Cyclosporin soft capsule composition 失效
标题翻译：环孢菌素软胶囊组合物
公开(公告)号：US5639474A
公开(公告)日：1997-06-17
申请号：US427465
申请日：1995-04-24
申请人： Jong Soo Woo
发明人： Jong Soo Woo
IPC分类号： A61K38/13 , A61K9/10 , A61K9/48
CPC分类号： B82Y5/00 , A61K38/13 , Y10S514/885 , Y10S514/937 , Y10S514/962 , Y10S514/97 , Y10S514/975
摘要： The present invention relates to a microemulsion concentrate containing cyclosporin as an active ingredient, dimethylisosorbide as a cosurfactant, oil and a surfactant which is suitable for the formulation of a soft capsule for oral administration, said cyclosporin, dimethyl isosorbide, oil and surfactant being present in the ratio of 1:1-5:1-5:2-10, and preferably in the ratio of 1:2-4:2-5:2-4:7, by weight. Since dimethylisosorbide has substantially no membrane permeation property, the soft capsule preparation according to the present invention is outstandingly stable in comparison with the soft capsules containing ethanol, propylene glycol, transcutol, glycofurol, etc., as a cosurfactant in the prior art, and further provides an advantage in that the pharmaceutical effect, appearance and composition content of the soft capsule according to the present invention are not changed.
摘要翻译：本发明涉及含有环孢菌素作为活性成分的微乳液浓缩物，二甲基异山梨醇作为辅助表面活性剂，油和表面活性剂，其适用于配制口服软胶囊，所述环孢菌素，二甲基异山梨醇，油和表面活性剂存在于 1：1-5：1-5：2-10的比例，优选的比例为1：2-4：2-5：2-4：7。由于二甲基异山梨醇基本上没有膜渗透性，因此与现有技术中作为辅助表面活性剂的乙醇，丙二醇，吡咯醇，糖醇等软胶囊相比，本发明的软胶囊制剂显着稳定提供了根据本发明的软胶囊的药物作用，外观和组合物含量不改变的优点。

30. 发明申请

US20130071452A1 PHARMACEUTICAL COMPOSITION COMPRISING AMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF 审中-公开
标题翻译：包含其衍生物或药物可接受的盐的药物组合物
公开(公告)号：US20130071452A1
公开(公告)日：2013-03-21
申请号：US13699993
申请日：2011-06-10
申请人： Yong Il Kim , Kyeong Soo Kim , Ki Young Jang , Yo Han Kim , Jae Hyun Park , Jong Soo Woo
发明人： Yong Il Kim , Kyeong Soo Kim , Ki Young Jang , Yo Han Kim , Jae Hyun Park , Jong Soo Woo
IPC分类号： A61K47/24 , A61K31/517 , A61K47/12 , A61K9/20 , A61K9/48
CPC分类号： A61K47/24 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2077 , A61K9/4858 , A61K31/497 , A61K31/517 , A61K47/12 , C07D401/12 , C07D401/14
摘要： The present invention relates to a pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof, and an acidic additive. This composition, owing to improved stability even after a long-term storage, is suitable for inhibiting the growth of cancer cells.
摘要翻译：本发明涉及包含酰胺衍生物或其药学上可接受的盐和酸性添加剂的药物组合物。这种组合物由于长期保存后的稳定性的改善，适用于抑制癌细胞的生长。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式